bio2018-mybio-sessionicon-companypres

XyloCor Therapeutics Company Presentation

2:45 PM–3:00 PM Jun 3, 2019 (US - Eastern)

Theater 1

Description

XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our lead product candidate, XC001, is in clinical development for patients with refractory angina for which there are no treatment options. XyloCor also has a secondary product, XC002, in discovery stage, for patients with cardiac tissue damage from heart attacks.

Session ID: 551640

Tags